195 related articles for article (PubMed ID: 28647344)
1. Oncogene-Expressing Senescent Melanocytes Up-Regulate MHC Class II, a Candidate Melanoma Suppressor Function.
van Tuyn J; Jaber-Hijazi F; MacKenzie D; Cole JJ; Mann E; Pawlikowski JS; Rai TS; Nelson DM; McBryan T; Ivanov A; Blyth K; Wu H; Milling S; Adams PD
J Invest Dermatol; 2017 Oct; 137(10):2197-2207. PubMed ID: 28647344
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
[TBL] [Abstract][Full Text] [Related]
3. Amphiregulin Regulates Melanocytic Senescence.
Pommer M; Kuphal S; Bosserhoff AK
Cells; 2021 Feb; 10(2):. PubMed ID: 33562468
[TBL] [Abstract][Full Text] [Related]
4. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.
Vredeveld LC; Possik PA; Smit MA; Meissl K; Michaloglou C; Horlings HM; Ajouaou A; Kortman PC; Dankort D; McMahon M; Mooi WJ; Peeper DS
Genes Dev; 2012 May; 26(10):1055-69. PubMed ID: 22549727
[TBL] [Abstract][Full Text] [Related]
5. Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence.
de Keizer PL; Packer LM; Szypowska AA; Riedl-Polderman PE; van den Broek NJ; de Bruin A; Dansen TB; Marais R; Brenkman AB; Burgering BM
Cancer Res; 2010 Nov; 70(21):8526-36. PubMed ID: 20959475
[TBL] [Abstract][Full Text] [Related]
6. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence.
Kaplon J; Zheng L; Meissl K; Chaneton B; Selivanov VA; Mackay G; van der Burg SH; Verdegaal EM; Cascante M; Shlomi T; Gottlieb E; Peeper DS
Nature; 2013 Jun; 498(7452):109-12. PubMed ID: 23685455
[TBL] [Abstract][Full Text] [Related]
7. In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells.
Leikam C; Hufnagel AL; Otto C; Murphy DJ; Mühling B; Kneitz S; Nanda I; Schmid M; Wagner TU; Haferkamp S; Bröcker EB; Schartl M; Meierjohann S
Cell Death Dis; 2015 Apr; 6(4):e1711. PubMed ID: 25837487
[TBL] [Abstract][Full Text] [Related]
8. Alternative Wnt-signaling axis leads to a break of oncogene-induced senescence.
Kluge V; Kappelmann-Fenzl M; Fischer S; Zimmermann T; Pommer M; Kuphal S; Bosserhoff AK
Cell Death Dis; 2024 Feb; 15(2):166. PubMed ID: 38388496
[TBL] [Abstract][Full Text] [Related]
9. C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells.
Zhuang D; Mannava S; Grachtchouk V; Tang WH; Patil S; Wawrzyniak JA; Berman AE; Giordano TJ; Prochownik EV; Soengas MS; Nikiforov MA
Oncogene; 2008 Nov; 27(52):6623-34. PubMed ID: 18679422
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7.
Wajapeyee N; Serra RW; Zhu X; Mahalingam M; Green MR
Cell; 2008 Feb; 132(3):363-74. PubMed ID: 18267069
[TBL] [Abstract][Full Text] [Related]
11. Wnt signaling potentiates nevogenesis.
Pawlikowski JS; McBryan T; van Tuyn J; Drotar ME; Hewitt RN; Maier AB; King A; Blyth K; Wu H; Adams PD
Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16009-14. PubMed ID: 24043806
[TBL] [Abstract][Full Text] [Related]
12. PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells.
Mannava S; Omilian AR; Wawrzyniak JA; Fink EE; Zhuang D; Miecznikowski JC; Marshall JR; Soengas MS; Sears RC; Morrison CD; Nikiforov MA
Oncogene; 2012 Mar; 31(12):1484-92. PubMed ID: 21822300
[TBL] [Abstract][Full Text] [Related]
13. Escape from p21-mediated oncogene-induced senescence leads to cell dedifferentiation and dependence on anti-apoptotic Bcl-xL and MCL1 proteins.
de Carné Trécesson S; Guillemin Y; Bélanger A; Bernard AC; Preisser L; Ravon E; Gamelin E; Juin P; Barré B; Coqueret O
J Biol Chem; 2011 Apr; 286(15):12825-38. PubMed ID: 21292770
[TBL] [Abstract][Full Text] [Related]
14. The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.
Yu H; McDaid R; Lee J; Possik P; Li L; Kumar SM; Elder DE; Van Belle P; Gimotty P; Guerra M; Hammond R; Nathanson KL; Dalla Palma M; Herlyn M; Xu X
Am J Pathol; 2009 Jun; 174(6):2367-77. PubMed ID: 19389934
[TBL] [Abstract][Full Text] [Related]
15. Role of melanoma inhibitory activity in melanocyte senescence.
Feuerer L; Lamm S; Henz I; Kappelmann-Fenzl M; Haferkamp S; Meierjohann S; Hellerbrand C; Kuphal S; Bosserhoff AK
Pigment Cell Melanoma Res; 2019 Nov; 32(6):777-791. PubMed ID: 31172672
[TBL] [Abstract][Full Text] [Related]
16. Oncogene-induced senescence: a double edged sword in cancer.
Liu XL; Ding J; Meng LH
Acta Pharmacol Sin; 2018 Oct; 39(10):1553-1558. PubMed ID: 29620049
[TBL] [Abstract][Full Text] [Related]
17. Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice.
Goel VK; Ibrahim N; Jiang G; Singhal M; Fee S; Flotte T; Westmoreland S; Haluska FS; Hinds PW; Haluska FG
Oncogene; 2009 Jun; 28(23):2289-98. PubMed ID: 19398955
[TBL] [Abstract][Full Text] [Related]
18. Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression.
Katlinskaya YV; Katlinski KV; Yu Q; Ortiz A; Beiting DP; Brice A; Davar D; Sanders C; Kirkwood JM; Rui H; Xu X; Koumenis C; Diehl JA; Fuchs SY
Cell Rep; 2016 Apr; 15(1):171-180. PubMed ID: 27052162
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic Braf induces melanocyte senescence and melanoma in mice.
Dhomen N; Reis-Filho JS; da Rocha Dias S; Hayward R; Savage K; Delmas V; Larue L; Pritchard C; Marais R
Cancer Cell; 2009 Apr; 15(4):294-303. PubMed ID: 19345328
[TBL] [Abstract][Full Text] [Related]
20. Cystathionase mediates senescence evasion in melanocytes and melanoma cells.
Leikam C; Hufnagel A; Walz S; Kneitz S; Fekete A; Müller MJ; Eilers M; Schartl M; Meierjohann S
Oncogene; 2014 Feb; 33(6):771-82. PubMed ID: 23353821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
